NANX Company Report

Solesence reported Q3 2025 revenue of $14.5 million, marking a 14% decrease year-over-year, and a net loss of $1.1 million compared to net income of $3 million in Q3 2024.
The gross margin for Q3 2025 was 23%, a decline from 36% in Q3 2024, primarily due to manufacturing operating inefficiencies and facilities improvements.
Kevin Cureton was appointed President and CEO, succeeding Jess, and the company is implementing operational improvements focused on product design, labor efficiency (reducing average labor cost per unit by 25% year-over-year), and inventory control.
For the full year 2025, Solesence projects revenue to be around $64 million, an increase of approximately $12 million over the prior year, and aims for future gross margins of at least 30%, with a long-term objective of 40%+.
The Q3 2025 results included a $1.2 million payment from the Employee Retention Credit Program and $300,000 in related interest, which positively impacted the bottom line.

Nov 11, 2025, 1:30 PM

Solésence Announces Uplisting to Nasdaq

NANX

Delisting/Listing Issues

Solésence, Inc. secured approval to transfer its listing from OTCQB to the Nasdaq Capital Market, with trading set to begin on April 8, 2025, under the new ticker SLSN.
Shareholders are not required to take any action as the uplisting is expected to boost the company's visibility and investor base.

Apr 7, 2025, 12:00 AM

Nanophase Technologies Reports Q4 2024 Record Revenue and Strategic Uplisting Plans

NANX

Earnings

Revenue Acceleration/Inflection

Delisting/Listing Issues

Achieved record net profit with Q4 revenue of $12.6 million—a 57% YoY increase—and improved gross margins (22% in Q4, 31% for the full year).
Expanded operational capacity by enhancing batch production at its Bolingbrook facility, supporting over $200 million in annual consumer product sales and doubling unit production versus Q4 2023.
Announced strategic initiatives including a rebranding to Solesence, plans for a Nasdaq uplisting in 2025, and investments in product innovations such as the award-winning Au Lait Face Milk SPF 50+.

Mar 27, 2025, 12:01 PM

NANOPHASE TECHNOLOGIES Reports Record Q4 and Full-Year 2024 Results

NANX

Earnings

Revenue Acceleration/Inflection

Q4 2024 performance: Revenue increased 57.5% to a record $12.6 million with gross profit reaching $2.8 million and an improved gross margin of 22% compared to the previous year.
Full-year results: Annual revenue surged 40% to $52.3 million, with net income turning positive at $4.2 million following a net loss in the prior year.
Operational highlights: The company expanded its production capabilities at the Bolingbrook facility and significantly increased unit production volume, while launching over two dozen new SKUs to enhance its customer mix.